FDA'S DTC Task | GenomeWeb

FDA'S DTC Task

In the weeks since the Food and Drug Administration told 23andMe that it must cease marketing its personal genome service there has been quite a bit of chatter about how the agency is being overly cautious, or too paternalistic, grinding up the gears of a fledgling industry while telling the American public that it knows better than them about what health information they can handle.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.